Cryptic antigen identified as new immunotherapy target for ovarian cancer
Mayo Clinic researchers have discovered a new immunotherapy target, a cryptic antigen, that may be key in helping the immune system fight tumors in ovarian cancer. The study, published in Science ...
The American Journal of Managed Care6h
Ovarian Cancer Remission Rates Remained Stable Before, After COVID-19 Pandemic
The comparable rates of remission pre- and post-pandemic suggest that COVID-19 did not negatively impact the outcomes of ...
KIMT7h
Mayo Clinic researchers identify new immunotherapy target for ovarian cancer
Mayo Clinic researchers say because ovarian cancer has limited symptoms, it can go undetected until it has spread. At a later ...
What Is Polycystic Ovary Syndrome? What Women Need to Know
Polycystic ovary syndrome (PCOS), also called polycystic ovarian syndrome, is a condition that impacts women of reproductive ...
Too Old to Operate1d
Primary Cytoreductive Surgery Improves Survival in Stage IV Ovarian Cancer
The following is a summary of “Survival outcomes of primary vs interval cytoreductive surgery for International Federation of Gynecology and Obstetrics stage IV ovarian cancer: a nationwide population ...
ascopubs.org3d
Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update
To provide updated guidance regarding neoadjuvant chemotherapy (NACT) and primary cytoreductive surgery (PCS) among patients with stage III-IV epithelial ovarian, fallopian tube, or primary peritoneal ...